HeartBeam appoints Ken Persen as CTO; enters LIVMOR partnership amendment

HeartBeam, Inc.

Ken Persen named CTO effective Aug 2, 2022; $300k annual salary, bonus up to 30% tied to FDA submission and corporate goals, 80k stock option.
Entered supplemental agreement with LIVMOR: paid $200k for source code access; licenses become non-exclusive, perpetual, royalty-free.
Persen previously LIVMOR CTO/CEO; over 28 years in cardiac devices and digital health, including Guidant and Cameron Health.
Partnership to create a company-branded version of LIVMOR's Halo+ remote patient monitoring solution for physicians and patients.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ken Persen

Chief Technical Officer

BEAT · HeartBeam, Inc.

Effective: 2022-08-02
Filed: August 8, 2022, 7:59 PM ET

On August 2, 2022, the Board of Directors (the “ Board ”) of the Company appointed Ken Persen as Chief Technical Officer of the Company (the “ Appointment ”) effective as of August 2, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ken Persen was appointed as Chief Technical Officer at HeartBeam, Inc..

Action: appointed
Role: Chief Technical Officer

Exact text from the filing

On August 2, 2022, the Board of Directors (the “ Board ”) of the Company appointed Ken Persen as Chief Technical Officer of the Company (the “ Appointment ”) effective as of August 2, 2022.

View on SEC.gov

HeartBeam, Inc. filing history →

Source: SEC EDGAR

accession 0001779372-22-000033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.